0001562180-19-005773.txt : 20191129 0001562180-19-005773.hdr.sgml : 20191129 20191129134447 ACCESSION NUMBER: 0001562180-19-005773 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20191126 FILED AS OF DATE: 20191129 DATE AS OF CHANGE: 20191129 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MEIER RICHARD A CENTRAL INDEX KEY: 0001227305 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36545 FILM NUMBER: 191260815 MAIL ADDRESS: STREET 1: 1700 E ST ANDREW PLACE CITY: SANTA ANA STATE: CA ZIP: 92705 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Intersect ENT, Inc. CENTRAL INDEX KEY: 0001271214 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 200280837 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1555 ADAMS DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-641-2100 MAIL ADDRESS: STREET 1: 1555 ADAMS DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 FORMER COMPANY: FORMER CONFORMED NAME: SINEXUS INC DATE OF NAME CHANGE: 20031124 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2019-11-26 false 0001271214 Intersect ENT, Inc. XENT 0001227305 MEIER RICHARD A C/O INTERSECT ENT, INC. 1555 ADAMS DRIVE MENLO PARK CA 94025 false true false false EVP & Chief Financial Officer Common Stock 2019-11-26 4 A false 52241.00 0.00 A 52241.00 D Common Stock 2019-11-26 4 A false 57230.00 0.00 A 109471.00 D Stock Options (Right to buy) 21.60 2019-11-26 4 A false 74852.00 0.00 A 2029-11-26 Common Stock 74852.00 74852.00 D Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan. Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting. The restricted stock units vest in three equal annual installments commencing one year after the grant date. Restricted stock units. Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan. Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting. The restricted stock units shall vest on the third anniversary from the date of grant provided that certain 30-day trailing average stock price (the "Average Closing Price") targets are achieved at any time during the three year period following the date of grant. 33 1/3%, 66 2/3% or 100% of the shares will vest if the Average Closing Price equals or exceeds specific stock price targets. Restricted stock units, of which 57,230 are performance based. The vesting commencement date of the option is November 26, 2019. 1/4th of the shares subject to the option shall vest on November 26, 2020 and 1/48th of the shares subject to the option shall vest monthly thereafter over 36 months. /s/ David A. Lehman, Attorney-in-Fact for Richard A Meier 2019-11-29 EX-24 2 poarichardmeier.txt POWER OF ATTORNEY POWER OF ATTORNEY Know all by these present, that the undersigned hereby constitutes and appoints each of THOMAS A. WEST and DAVID A. LEHMAN, signing individually, the undersigned's true and lawful attorneys-in fact and agents to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer, director or beneficial owner of more than 10% of a registered class of securities of Intersect ENT, Inc. (the "Company"), (a) Forms 3, 4 and 5 (including any amendments thereto) in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") and the rules thereunder and a (b) Form ID, Uniform Application for Access Codes to File on EDGAR; (2) do and perform any and all acts for and on behalf of the undersigned that may be necessary or desirable to execute such Forms 3, 4 or 5 or Form ID (including any amendments thereto) and timely file such forms with the United States Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action of any nature whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in- fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in- fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Exchange Act. This Power of Attorney shall remain in full force and effect until the earliest to occur of (a) the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, (b) revocation by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact or (c) as to any attorney-in-fact individually, until such attorney-in- fact is no longer employed by the Company. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of November 26th, 2019. /s/ Richard A Meier Richard A. Meier 1 108990461 v1